PerkinElmer Revenue and Competitors
Estimated Revenue & Valuation
- PerkinElmer's estimated annual revenue is currently $5.1B per year.
- PerkinElmer's estimated revenue per employee is $440,728
- PerkinElmer's total funding is $6.9M.
- PerkinElmer's current valuation is $22.5B. (January 2022)
Employee Data
- PerkinElmer has 11481 Employees.
- PerkinElmer grew their employee count by 6% last year.
PerkinElmer Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $584.7M | 2820 | 9% | $20M | N/A |
#2 | $5.1M | 44 | N/A | N/A | N/A |
#3 | $8.5M | 67 | -19% | $950K | N/A |
#4 | $3.9M | 35 | -44% | $30M | N/A |
#5 | $0.7M | 9 | N/A | N/A | N/A |
#6 | $0.7M | 9 | N/A | N/A | N/A |
#7 | $0.6M | 8 | N/A | N/A | N/A |
#8 | $2.4M | 24 | N/A | N/A | N/A |
#9 | $87.7M | 314 | 28% | N/A | N/A |
#10 | $13.6M | 94 | N/A | N/A | N/A |
#11 | $57.4M | 323 | -2% | $8M | N/A |
#12 | $3.7M | 32 | N/A | N/A | N/A |
#13 | $3.4M | 17 | N/A | N/A | N/A |
#14 | $2.6M | 26 | N/A | N/A | N/A |
#15 | $24.7M | 155 | N/A | N/A | N/A |
#16 | $964.4M | 4798 | N/A | N/A | N/A |
#17 | $13.7M | 68 | N/A | N/A | N/A |
#18 | $7.8M | 77 | 45% | $17.2M | N/A |
#19 | N/A | 30 | N/A | N/A | N/A |
#20 | $1.6M | 22 | -4% | $5.1M | N/A |
What Is PerkinElmer?
$6.9M
Total Funding
11481
Number of Employees
$5.1B
Revenue (est)
6%
Employee Growth %
$22.5B
Valuation
N/A
Accelerator
PerkinElmer News
PerkinElmer, Inc. (NYSE:PKI) Given Consensus Rating of Buy by Brokerages. Posted by admin on Apr 25th, 2022. Share on Twitter Share on Facebook Share on...
The letter thanked PerkinElmer for its partnership and noted the increased availability of antigen testing and expanded commercial testing...
The cuts are linked to a contract PerkinElmer signed with California's Department of Public Health (CDPH) in August 2020 to provide COVID-19 lab testing and...
PerkinElmer, Inc. (NYSE: PKI) entered into an agreement to acquire San Diego-based BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion. The acquisition deal will be a combination of cash and stock, subject to certain adjustments accordin ...
PDF Version Non-invasive sampling method makes it easier to use the highly sensitive molecular test manufactured by PerkinElmer WHAT:PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the U.S. Food and Drug Administration (FDA) has authorized ...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5323.6M | 22368 | N/A | N/A |
#2 | $11778.8M | 30507 | 5% | $66.5M |
#3 | $39060M | 69756 | 15% | $30B |
#4 | $30778.2M | 71378 | N/A | N/A |
#5 | $63760M | 72676 | N/A | N/A |
